These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 13748426)

  • 1. [On the pharmacology of 1-phenyl-2,3-dimethyl-4-isopropylaminopyrazolone (isopyrin) and 1,2-diphenyl-4-butyl-3,5-pyradolidinedione (phenylbutazone)].
    SCHOETENSACK W; RICHARZ G; BISCHLER P
    Arzneimittelforschung; 1960 Aug; 10():665-76. PubMed ID: 13748426
    [No Abstract]   [Full Text] [Related]  

  • 2. [Distribution and excretion of 1-phenyl-2,3-dimethyl-4-isopropylamino-pyrazolone (isopyrin) as well as of phenylbutazone in the rat].
    RICHARZ G; SCHOETENSACK W; VOGEL M
    Arzneimittelforschung; 1960 Aug; 10():676-83. PubMed ID: 13741316
    [No Abstract]   [Full Text] [Related]  

  • 3. [On the effect of 3, 5-dioxo-1, 2-diphenyl-4-butylpyrazolidine on the synthesis of fatty acids].
    von BRAND
    Arzneimittelforschung; 1959 Dec; 9():767-9. PubMed ID: 13803850
    [No Abstract]   [Full Text] [Related]  

  • 4. Analgesics. V. Pyrazolon derivatives: antipyrine (phenazone), aminopyrine (pyramidon), and phenylbutazone (butazolidin).
    BANERJI LK
    Indian J Med Sci; 1961 Jan; 15():51-5. PubMed ID: 13686561
    [No Abstract]   [Full Text] [Related]  

  • 5. [The effect of 3,5-dioxo-1,2-diphenyl-4-n-butyl pyrazolidine and 3,5-dioxo-1-phenyl-2-p-hydroxyphenyl-4-butyl pyrazolidine on the incorporation of C14-leucine into the blood plasma proteins of the isolated rat liver].
    JUNGBLUT PW
    Arzneimittelforschung; 1959 Sep; 9():549-51. PubMed ID: 14408193
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparative studies on the action of 4-butyl-1,2-diphenyl-3, 5-pyrazolidinedione on embryonal fibroblasts, blood and bone marrow cells in vitro].
    ALBRECHT M; ESCHENBACH J; KRETSCHMER V
    Arzneimittelforschung; 1960 Aug; 10():606-12. PubMed ID: 13682160
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of internal diseases with 4-butyl-1, 2-diphenyl-3, 5-pyrazolidinedione and a combination of this drug with 4-dimethylamino-2, 3-dimethyl-1-phenyl-3-pyrazolin-5-one].
    BEHRE R
    Arzneimittelforschung; 1958 Aug; 8(8):520-5. PubMed ID: 13584244
    [No Abstract]   [Full Text] [Related]  

  • 8. [The influence of 1-phenyl-3,5-dioxo-4-n-butyl-pyrazolidine on hyaluronidase spreading].
    MATHIES H; WILL E; SCHUELE V
    Med Monatsschr; 1962 Aug; 16():537-40. PubMed ID: 14471124
    [No Abstract]   [Full Text] [Related]  

  • 9. [The osmotic behavior of normal, of inflamed, and of 1,2-diphenyl-4-butyl-3,5-pyrazolidinedione-treated rat liver slices].
    BURCK HC
    Arzneimittelforschung; 1960 Sep; 10():752-5. PubMed ID: 13688929
    [No Abstract]   [Full Text] [Related]  

  • 10. [Acid-base equilibrium in connective tissue and dependent changes under the influence of 1, 2-diphenyl-4-butyl-3,5-pyrazolidinedione. 2. Practical performance of the investigations].
    ECKSTEIN M; LINDNER J; von SCHWEINITZ H
    Arzneimittelforschung; 1960 Nov; 10():902-9. PubMed ID: 13725632
    [No Abstract]   [Full Text] [Related]  

  • 11. [Acid-base equilibrium in connective tissue and dependent changes under the influence of 1, 2-diphenyl-4-butyl-3, 5-pyrazolidine-dione. 1. Theoretical basis].
    von SCHWEINITZ H; LINDNER J; ECKSTEIN M
    Arzneimittelforschung; 1960 Nov; 10():899-901. PubMed ID: 13749227
    [No Abstract]   [Full Text] [Related]  

  • 12. [Synergy of the analgesic actions of Phebuzin and Isopyrin].
    Saraiva PA; Ramos AO; Ramos L; Adachi T; Cunha MA
    Arch Int Pharmacodyn Ther; 1966 Feb; 159(2):299-309. PubMed ID: 5916735
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of 1,2-diphenyl-3,5-diexe-4-n-butyl-pyrazolidine on the permaeability of blood-brain-barrier in animal experiments].
    Tzonos T
    Arzneimittelforschung; 1967 Apr; 17(4):509-11. PubMed ID: 5632452
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of 3,5-dioxo-1,2-diphenyl-4-n-butyl-pyrazolidine on phosphatases. 2].
    OHLMEYER P; KROMER H
    Arzneimittelforschung; 1958 Apr; 8(4):247-8. PubMed ID: 13535368
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of 3, 5-dioxo-1, 2-diphenyl-4-n-butyl-pyrazolidine on phosphatases].
    HAHN E; PLATE B
    Arzneimittelforschung; 1956 Dec; 6(12):728-9. PubMed ID: 13395936
    [No Abstract]   [Full Text] [Related]  

  • 16. [The isopyrine-phenylbutazone combination in rheumatology. Some clinical observations].
    ROSSELLE N; VAN BETBRUGGE A; CLAEYSG ; MAGNUS L
    Scalpel (Brux); 1961 Sep; 114():825-32. PubMed ID: 14494244
    [No Abstract]   [Full Text] [Related]  

  • 17. [Toxicity and kinetics of the elimination of 4-butyl-2-phenyl-3, 5-pyrazolidinedione compared with that of the 1,2-diphenyl derivative].
    SCARSELLI V
    Farmaco Sci; 1959; 14(5):347-51. PubMed ID: 13663921
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical trial of a new anti-rheumatic agent, pyrazolonepyrazolidine derivative].
    CIOCCI A
    Minerva Med; 1960 Oct; 51():3496-501. PubMed ID: 13693702
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of 3, 5-dioxo-1, 2-diphenyl-4-n-butyl-pyrazolidine (butazolidine) on cortisone metabolism in rat liver].
    DIRSCHERL W; KORUS W; SCHRIEFERS H
    Arzneimittelforschung; 1956 Oct; 6(10):596-8. PubMed ID: 13373678
    [No Abstract]   [Full Text] [Related]  

  • 20. [Considerations on the clinical use of a new preparation with a pyrazolone-pyrazolidine base in rheumatological and traumatological fields].
    PADOVANI PU
    Minerva Med; 1960 Oct; 51():3559-64. PubMed ID: 13731983
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.